Risperidone versus haloperidol versus placebo in the treatment of schizophrenia Posted on March 31, 2016 by tsuperadmin -
Risperidone in the treatment of behavioural disturbances in patients with Alzheimer’s dementia: a double-blind placebo-controlled trial Posted on March 31, 2016 by tsuperadmin -
NCT00270283 – A Double-Blind, Placebo-Controlled Study With Open-Label Follow-up to Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy Posted on October 20, 2015 by tsuperadmin -
NCT00074477 – A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of 50 and 100 Mg-eq of Paliperidone Palmitate in Patients With Schizophrenia Posted on October 20, 2015 by tsuperadmin -
NCT00910871 – A Phase II, Open-label Trial With TMC207 as Part of a Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Subjects With Sputum Smear-positive Pulmonary Infection With MDR-TB Posted on May 15, 2015 by tsuperadmin -
NCT00449644 – A Phase II, Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Subjects With Newly Diagnosed Sputum Smear-positive Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB). Posted on May 15, 2015 by tsuperadmin -
NCT00642278 – A Randomized, Double-Blind, Placebo-Controlled, Double-Dummy, Parallel Group, Multicenter, Dose-Ranging Study in Subjects With Type 2 Diabetes Mellitus to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered SGLT2 Inhibitor JNJ-28431754 With Sitagliptin as a Reference Arm Posted on October 20, 2014 by tsuperadmin -
The YODA Project